Edesa Biotech, Inc.【EDSA】Cash flow
Market cap
$35.96M
P/E ratio
| 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Depreciation & amortization | 159,521 | 149,565 | 179,322 | - | - | - | - | - | 186,049 |
| Stock-based compensation | 267,222 | 259,379 | 115,546 | 154,313 | 598,359 | 3 | 2 | 1 | 537,492 |
| Cash from operations | -4,412,395 | -4,505,629 | -4,699,649 | -4,615,505 | -4,986,340 | -13,664,932 | -12,279,302 | -6,636,483 | -5 |
| Capital expenditures | -274,589 | -402,271 | -302,733 | -382,810 | -4,856 | -6,146 | -5,656 | - | - |
| Cash from investing | 122,470 | 557,411 | 2 | -4,466,440 | 19,073 | -6,146 | -5,656 | - | - |
| Cash from financing | 106,777 | 7 | - | 9 | 7 | 14 | 12 | 5 | 592,031 |
| Free cash flow | - | - | |||||||
| FCF margin (%) | - | - | - | - |